2-[2-butyl-3-[4-(3,5-diphenylphenyl)cyclohexa-1,3-dien-1-yl]phenyl]-3-methyl-6-phenyldibenzofuran
C53H44O — CID 143905011
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-butyl-3-[4-(3,5-diphenylphenyl)cyclohexa-1,3-dien-1-yl]phenyl]-3-methyl-6-phenyldibenzofuran
2-[2-butyl-3-[4-(3,5-diphenylphenyl)cyclohexa-1,3-dien-1-yl]phenyl]-3-methyl-6-phenyldibenzofuran (PubChem CID 143905011) has the molecular formula C53H44O and a molecular weight of 696.93 g/mol. Its IUPAC name is 2-[2-butyl-3-[4-(3,5-diphenylphenyl)cyclohexa-1,3-dien-1-yl]phenyl]-3-methyl-6-phenyldibenzofuran.
Molecular Properties
| Compound Name | 2-[2-butyl-3-[4-(3,5-diphenylphenyl)cyclohexa-1,3-dien-1-yl]phenyl]-3-methyl-6-phenyldibenzofuran |
|---|---|
| PubChem CID | 143905011 |
| Molecular Formula | C53H44O |
| Molecular Weight | 696.93 g/mol |
| Exact Mass | 696.34 |
| IUPAC Name | 2-[2-butyl-3-[4-(3,5-diphenylphenyl)cyclohexa-1,3-dien-1-yl]phenyl]-3-methyl-6-phenyldibenzofuran |
| SMILES | CCCCc1c(C2=CC=C(c3cc(-c4ccccc4)cc(-c4ccccc4)c3)CC2)cccc1-c1cc2c(cc1C)oc1c(-c3ccccc3)cccc12 |
| InChI | InChI=1S/C53H44O/c1-3-4-22-47-45(41-29-27-39(28-30-41)44-33-42(37-16-8-5-9-17-37)32-43(34-44)38-18-10-6-11-19-38)23-14-25-48(47)50-35-51-49-26-15-24-46(40-20-12-7-13-21-40)53(49)54-52(51)31-36(50)2/h5-21,23-27,29,31-35H,3-4,22,28,30H2,1-2H3 |
| InChIKey | WBQNMMULWPAFAY-UHFFFAOYSA-N |
| XLogP | 15.17 |
| TPSA | 13.14 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 1 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 54 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 696.93 |
| LogP ≤ 5 | 15.17 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 1 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143905011 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.